Stable Cell Line for Production of PAT-DX3 Established
Filed with ASX · · 2 pages · English
Story so far
Earlier from Patrys
- Appendix 4D - Half Year Accounts - 31 December 2021
- Appendix 4C - Quarterly - 31 December 2021
- PAT-DX1 engineering update
- Ceasing to be a substantial holder from MQG
- Change of Director's Interest Notices x2
Later from Patrys
- Application for quotation of securities - PAB
- Appendix 4C - Quarterly - 31 March 2022
- CBCF funding to support deoxymab brain cancer development
- New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis
- PAT-DX1 Engineering Run Successfully Completed
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys